TARIS Biomedical Appoints Julie Lekstrom Himes, MD, to CMO Post
11/6/2009 9:24:35 AM
LEXINGTON, Mass.--(BUSINESS WIRE)--TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, announced today the appointment of Julie Lekstrom Himes, M.D. to join TARIS in the position of Chief Medical Officer and Senior Vice President for Clinical Development. Dr. Himes has broad clinical research and operations experience within the biopharmaceutical industry, including Coley Pharmaceuticals and Millennium Pharmaceuticals. Prior to joining industry, Dr. Himes held academic positions at the National Institutes of Health in the Allergy and Infectious Diseases and Human Genome Research Institutes.